Nucleai Closes $33 Million Series B Financing to Advance Spatial Biology Platform for Drug Research,…
Led by Section 32 and Sanofi Ventures, funding will enable Nucleai to expand its commercial footprint in biopharma and further develop its…
Artificial Intelligence | News | Insights | AiThority